3-Methylbutanoic Acid

3-Methylbutanoic Acid

SCHEMBL945839

CC(C)CC(=O)O.CC(O)CO

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of 3-Methylbutanoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.53
SLC22A6 Q4U2R8 1/20 0.46
ALDH1A1 P00352 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
CACNA2D1 P54289 2/20 0.41
CACNB3 P54284 1/20 0.41
CACNA1C Q13936 1/20 0.41
PGR P06401 1/20 0.41
ADRA1A P35348 1/20 0.41
HTR2B P41595 1/20 0.41
CACNA2D2 Q9NY47 1/20 0.41
MME P08473 2/20 0.40
CA2 P00918 1/20 0.40
TSHR P16473 1/20 0.40
MAPT P10636 1/20 0.39
GABRR1 P24046 2/20 0.39
LMNA P02545 1/20 0.39
OR51E2 Q9H255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
3-Methylbutanoic Acid SCHEMBL27465475 0.87 SLC22A6 (0.50) TDP1SLC22A6ALDH1A1SMN1; SMN2CACNA2D1
3-Methylbutanoic Acid SCHEMBL1331498 0.86
3-Methylbutanoic Acid SCHEMBL43436 0.86
3-Methylbutanoic Acid SCHEMBL467274 0.86 TDP1 (0.56) TDP1SLC22A6ALDH1A1SMN1; SMN2CACNA2D1
3-Methylbutanoic Acid SCHEMBL1373554 0.83 TDP1 (0.48) TDP1SLC22A6ALDH1A1SMN1; SMN2CACNA2D1
3-Methylbutanoic Acid SCHEMBL6113289 0.83
3-Methylbutanoic Acid SCHEMBL9185998 0.83
3-Methylbutanoic Acid SCHEMBL6139482 0.83
3-Methylbutanoic Acid SCHEMBL15772049 0.83
3-Methylbutanoic Acid SCHEMBL8572477 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220323912-A1 LIQUID PURIFICATION MEMBRANE INCLUDING CARBONACEOUS MATERIALS AND METHODS OF FORMING THEM MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT 2022-10-13 US claimed
EP-0907673-A4 TWO-COMPONENT WATERBORNE POLYURETHANE COATING ARCO CHEM TECH (US) 1999-11-10 EP claimed
EP-0907673-A1 TWO-COMPONENT WATERBORNE POLYURETHANE COATING ARCO Chemical Technology, L.P. (US) 1999-04-14 EP claimed
WO-1997045475-A1 TWO-COMPONENT WATERBORNE POLYURETHANE COATING ARCO CHEMICAL TECHNOLOGY, L.P. (US) 1997-12-04 WO claimed
US-20260125596-A1 CURABLE COMPOSITION, CURED LAYER USING THE COMPOSITION AND DISPLAY DEVICE INCLUDING THE CURED LAYER SAMSUNG SDI CO LTD (KR) 2026-05-07 US disclosed
US-20260118551-A1 CORE-SHELL COMPOUND, PHOTOSENSITIVE RESIN COMPOSITION INCLUDING THE SAME, PHOTOSENSITIVE RESIN LAYER, COLOR FILTER, AND CMOS IMAGE SENSOR SMSUNG SDI CO LTD (KR) 2026-04-30 US disclosed
US-12606650-B2 Curable composition, cured film manufactured using composition, color filter including cured film, and display device including color filter SAMSUNG SDI CO., LTD. (KR) 2026-04-21 US disclosed
US-20260001971-A1 CURABLE COMPOSITION, CURED LAYER USING THE COMPOSITION AND DISPLAY DEVICE INCLUDING THE CURED LAYER SAMSUNG SDI CO LTD (KR) 2026-01-01 US disclosed
US-20260003272-A1 CURABLE COMPOSITION, CURED LAYER USING THE COMPOSITION, AND DISPLAY DEVICE INCLUDING THE CURED LAYER SAMSUNG SDI CO LTD (KR) 2026-01-01 US disclosed
US-20250326876-A1 CURABLE COMPOSITION, CURED LAYER MANUFACTURED USING SAME COMPOSITION, COLOR FILTER INCLUDING SAME CURED LAYER, AND DISPLAY DEVICE INCLUDING SAME COLOR FILTER SAMSUNG SDI CO LTD (KR) 2025-10-23 US disclosed
US-20250304733-A1 CURABLE COMPOSITION, CURED LAYER USING THE COMPOSITION, COLOR FILTER INCLUDING THE CURED LAYER AND DISPLAY DEVICE INCLUDING THE COLOR FILTER SAMSUNG SDI CO., LTD. (KR) 2025-10-02 US disclosed
US-12365833-B2 Curable composition, cured film produced using same, and color filter comprising same SAMSUNG SDI CO., LTD. (KR) 2025-07-22 US disclosed
US-20100167188-A1 Pigment Dispersion Composition, Resist Composition for Color Filter Including the Same, and Color Filter Using the Same CHEIL INDUSTRIES INC. (KR) 2010-07-01 US disclosed
WO-2010050650-A1 PIGMENT DISPERSION COMPOSITION AND COLOR RESIST COMPOSITION INCLUDING THE SAME AND COLOR FILTER USING THE SAME CHEIL INDUSTRIES INC. (KR) 2010-05-06 WO disclosed
EP-1219662-B1 POLYAMIC ACID ESTER ASAHI CHEMICAL IND (JP) 2004-08-04 EP disclosed
US-6692873-B1 IMPROVING PRODUCTIVITY; EMPLOYING PROPYLENE GLYCOL METHYL ETHER ACETATE, PROPYLENE GLYCOL MONOMETHYL ETHER OR PROPYLENE GLYCOL MONOETHYL ETHER AS PLASTICIZER WHICH CAN BE REMOVED UNDER VACUUM ELIMINATING SOLVENT EXTRACTION SKC CO., LTD. (KR) 2004-02-17 US disclosed
EP-1219662-A1 POLYAMIC ACID ESTER Asahi Kasei Kabushiki Kaisha (JP) 2002-07-03 EP disclosed
EP-0907673-A4 TWO-COMPONENT WATERBORNE POLYURETHANE COATING ARCO CHEM TECH (US) 1999-11-10 EP disclosed
EP-0907673-A1 TWO-COMPONENT WATERBORNE POLYURETHANE COATING ARCO Chemical Technology, L.P. (US) 1999-04-14 EP disclosed
WO-1997045475-A1 TWO-COMPONENT WATERBORNE POLYURETHANE COATING ARCO CHEMICAL TECHNOLOGY, L.P. (US) 1997-12-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12606650-B2 Curable composition, cured film manufactured using composition, color filter including cured film, and display device including color filter PRKD1, CRY2, PRKD2 TDP1 3996/4885SLC22A6 3910/4885ALDH1A1 1717/4885
US-20260001971-A1 CURABLE COMPOSITION, CURED LAYER USING THE COMPOSITION AND DISPLAY DEVICE INCLUDING THE CURED LAYER EPB41L2, CIB1, ILK TDP1 3436/4885SLC22A6 4736/4885ALDH1A1 306/4885
US-20260003272-A1 CURABLE COMPOSITION, CURED LAYER USING THE COMPOSITION, AND DISPLAY DEVICE INCLUDING THE CURED LAYER ILK, EPB41L2, LASP1 TDP1 3940/4885SLC22A6 4781/4885ALDH1A1 261/4885
US-20260118551-A1 CORE-SHELL COMPOUND, PHOTOSENSITIVE RESIN COMPOSITION INCLUDING THE SAME, PHOTOSENSITIVE RESIN LAYER, COLOR FILTER, AND CMOS IMAGE SENSOR RCOR1, TAS1R2, TAS1R1 TDP1 4611/4885SLC22A6 3413/4885ALDH1A1 1597/4885
US-20260125596-A1 CURABLE COMPOSITION, CURED LAYER USING THE COMPOSITION AND DISPLAY DEVICE INCLUDING THE CURED LAYER C5, CORO1C, CCT4 TDP1 4102/4885SLC22A6 4582/4885ALDH1A1 530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.